Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography–directed therapy for early-stage Hodgki... by Cutter, DJ, Ramroth, J, Diez, P, Buckle, A, Ntentas, G, Popova, B, Clifton-Hadley, L, Hoskin, PJ, Darby, SC, Radford, J, Illidge, T

Multi-center randomized phase II study comparing cediranib plus gefitinib with cediranib plus placebo in subjects with recurrent/progressive glioblastoma by Brown, N, McBain, C, Nash, S, Hopkins, K, Sanghera, P, Saran, F, Phillips, M, Dungey, F, Clifton-Hadley, L, Wanek, K, Krell, D, Jeffries, S, Khan, I, Smith, P, Mulholland, P